PL1709070T3 - Peptydy do leczenia chorób autoimmunologicznych - Google Patents

Peptydy do leczenia chorób autoimmunologicznych

Info

Publication number
PL1709070T3
PL1709070T3 PL05701998T PL05701998T PL1709070T3 PL 1709070 T3 PL1709070 T3 PL 1709070T3 PL 05701998 T PL05701998 T PL 05701998T PL 05701998 T PL05701998 T PL 05701998T PL 1709070 T3 PL1709070 T3 PL 1709070T3
Authority
PL
Poland
Prior art keywords
peptides
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Application number
PL05701998T
Other languages
English (en)
Inventor
Mark Peakman
Original Assignee
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0402129.1A external-priority patent/GB0402129D0/en
Priority claimed from GB0404199A external-priority patent/GB0404199D0/en
Application filed by King S College London filed Critical King S College London
Publication of PL1709070T3 publication Critical patent/PL1709070T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL05701998T 2004-01-30 2005-01-24 Peptydy do leczenia chorób autoimmunologicznych PL1709070T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0402129.1A GB0402129D0 (en) 2004-01-30 2004-01-30 Therapeutic and diagnostic peptides
US10/783,095 US7049292B2 (en) 2004-01-30 2004-02-23 Therapeutically effective peptides related to preproinsulin
GB0404199A GB0404199D0 (en) 2004-02-25 2004-02-25 Therapeutic and diagnostic peptides 2
PCT/GB2005/000236 WO2005073248A1 (en) 2004-01-30 2005-01-24 Peptides for treatment of autoimmune diseases
EP05701998.6A EP1709070B1 (en) 2004-01-30 2005-01-24 Peptides for treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
PL1709070T3 true PL1709070T3 (pl) 2014-01-31

Family

ID=34830844

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05701998T PL1709070T3 (pl) 2004-01-30 2005-01-24 Peptydy do leczenia chorób autoimmunologicznych

Country Status (5)

Country Link
US (1) US20060199228A1 (pl)
EP (1) EP1709070B1 (pl)
AU (1) AU2005209464B2 (pl)
PL (1) PL1709070T3 (pl)
WO (1) WO2005073248A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007032778A2 (en) * 2005-09-13 2007-03-22 Xencor, Inc. Analysis of mhc-peptide binding interactions via population specific mhc-arrays
GB0712670D0 (en) 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
US8889124B2 (en) * 2008-09-25 2014-11-18 The Board Of Trustees Of The Leland Stanford Junior University Tolerogenic populations of dendritic cells
GB201506112D0 (en) * 2015-04-10 2015-05-27 Midatech Ltd And Inst Nationale De La Sant� Et De Al Rech Medicale And University College Car Nanoparticle-based antigen specific immunotherapy
GB201510056D0 (en) * 2015-06-10 2015-07-22 King S College London Multi-peptide composition

Also Published As

Publication number Publication date
AU2005209464A1 (en) 2005-08-11
EP1709070A1 (en) 2006-10-11
WO2005073248A1 (en) 2005-08-11
US20060199228A1 (en) 2006-09-07
EP1709070B1 (en) 2013-05-29
AU2005209464B2 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
EP1951273A4 (en) USE OF LACTOBACILLUS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
GB2429013B (en) Peptides for treatment and diagnosis of autoimmune disease
IL177849A0 (en) Methods and compositions for treatment of autoimmune diseases
IL181305A0 (en) Combinations for the treatment of diseases involving cell proliferation
ZA200802935B (en) Use of lactobacillus for treatment of autoimmune diseases
EP1789069A4 (en) CYCLIC PEPTIDES FOR THE TREATMENT OF CACHEXIA
EP1781316A4 (en) CYCLIC PEPTIDES FOR THE TREATMENT OF CACHEXIA
EP1858524A4 (en) COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND RELATED DISEASES
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
AU2003298911A8 (en) Cyclosporins for the treatment of autoimmune diseases
PL2012814T3 (pl) Sposoby leczenia chorób autoimmunologicznych
PL1709070T3 (pl) Peptydy do leczenia chorób autoimmunologicznych
HK1155670A1 (en) Therapeutic use of anti-cs1 antibodies
EP1924286A4 (en) PROPHYLACTIC AND / OR THERAPEUTIC METHOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES
GB0526394D0 (en) Treatment of inflammatory diseases
ZA200802177B (en) TCR-V-Beta related peptides for treatment and diagnoses of autoimmune disease
IL178517A0 (en) Therapeutic peptides
ZA200606780B (en) Compounds for the treatment of diseases
ZA200609395B (en) Therapeutic peptides
GB0407710D0 (en) Treatment of diseases
GB0419594D0 (en) Therapeutic peptides
GB0405190D0 (en) Purification of peptides
AP2006003728A0 (en) Compounds for treatment of diseases
HU0302933D0 (en) Treatment of diseases
HU0400952D0 (en) Treatment of anus-cancer